These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9275545)

  • 1. [Granulocyte-macrophage colony-stimulating factor (GM-CSF), preclinical and phase I clinical investigations].
    Shen B; Yang Z; Xu J
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):654-7. PubMed ID: 9275545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can 29kDa rhGM-CSF expressed by silkworm pupae bioreactor bring into effect as active cytokine through orally administration?
    Zhang Y; Chen J; Lv Z; Nie Z; Zhang X; Wu X
    Eur J Pharm Sci; 2006 Jun; 28(3):212-23. PubMed ID: 16616462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant human granulocyte macrophage colony-stimulating factor in Macaca mulatta.
    Wang RG; Zhu XZ; Song W
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):50-3. PubMed ID: 10375759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor.
    Monroy RL; Skelly RR; Taylor P; Dubois A; Donahue RE; MacVittie TJ
    Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
    Madero L; Díaz MA; Ortega JJ; Olive T; Martínez A; Badell I; Muñoz A; Gómez P
    Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.
    Koukourakis MI; Flordellis CS; Giatromanolaki A; Koukouraki S; Kapsoritakis A; Potamianos S; Retalis G; Sivridis E; Salsaa B; Harris AL; Maragoudakis MI
    Clin Cancer Res; 1999 Dec; 5(12):3970-6. PubMed ID: 10632327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X; Shao Y; Ren B; Tong Z; Ren X; Li L; Zhang Z; Zhang N; Dai R; Hao X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):247-9. PubMed ID: 11876989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biologic effects and possible therapeutic use of the granulocyte-macrophage colony-stimulating factor. Modern treatment of leukopenia].
    Jovanović-Mićić D; Beleslin DB; Bosnjak S
    Srp Arh Celok Lek; 1993; 121(8-12):152-4. PubMed ID: 7725160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients.
    Kountouras J; Boura P; Tsapas G
    Hepatogastroenterology; 1998; 45(24):2295-302. PubMed ID: 9951912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of NGF on hematopoiesis of granulocyte-macrophage in normal and radiation, chemistry injury mice].
    Huang XQ; Zhu BD; Jiang-Yang-ze-ren
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):757-62. PubMed ID: 19024307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Akasheh M; Eastwood D; Vesole DH
    Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.
    Mels AK; Statius Muller MG; van Leeuwen PA; von Blomberg BM; Scheper RJ; Cuesta MA; Beelen RH; Meijer S
    Br J Surg; 2001 Apr; 88(4):539-44. PubMed ID: 11298622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
    Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
    Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rhGM-CSF-EPO hybrid protein MEN 11300 induces anti-EPO antibodies and severe anaemia in rhesus monkeys.
    Coscarella A; Liddi R; Di Loreto M; Bach S; Faiella A; van der Meide PH; Mele A; De Santis R
    Cytokine; 1998 Dec; 10(12):964-9. PubMed ID: 10049520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.